Evaluating lactate prognostic value in children suspected of acetaminophen-induced liver failure in Liberia

Mohamad K Haidar1,2, Nikola Morton3, Thomas Roederer4

  • 1Epicentre, Paris, France. mohamad.haidar193@gmail.com.

Pediatric Research
|January 30, 2020
PubMed

Insights

Hyperlactatemia in young children with acetaminophen-induced liver injury indicates poor prognosis. A lactate level above 7.2 mmol/L suggests a high risk of mortality in these pediatric cases.

Area of Science:

  • Pediatric Hepatology
  • Toxicology
  • Critical Care Medicine

Background:

  • Acetaminophen (paracetamol) overdose is a common cause of acute liver injury in children.
  • The prognostic value of hyperlactatemia in pediatric acetaminophen-induced liver injury (AILI) is not well-established.
  • Early identification of high-risk pediatric patients is crucial for timely intervention.

Purpose of the Study:

  • To investigate the prognostic significance of hyperlactatemia in young children with liver injury.
  • To determine the optimal lactate threshold for predicting mortality in pediatric acetaminophen toxicity.
  • To evaluate the utility of existing lactate thresholds in this specific population.

Main Methods:

  • Retrospective medical chart review of children under 5 years old admitted with hepatocellular injury.
  • Inclusion of patients with available blood lactate measurements on admission.
  • Analysis of mortality rates, acetaminophen concentrations, and lactate levels.

Main Results:

  • A total of 95 children were analyzed; 52% died during hospitalization.
  • Children who died had significantly higher median lactate levels (10.7 mmol/L) compared to survivors (6.1 mmol/L).
  • An optimal lactate threshold of 7.2 mmol/L predicted non-survival with 84% sensitivity and 70% specificity (AUC=0.80).

Conclusions:

  • Hyperlactatemia is a significant predictor of mortality in pediatric acetaminophen-induced liver injury.
  • A venous blood lactate concentration exceeding 7.2 mmol/L indicates a poor prognosis in young children with suspected acetaminophen toxicity.
  • Established lactate thresholds (3.5-4 mmol/L) are insufficient for identifying non-survival in this pediatric cohort.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
132
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
170
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
147
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
218